Evaluation of recurrence score and traditional clinicopathologic assessments in a large ER-positive, lymph node-negative patient cohort.

被引：1
|
作者：
Liebermann, N.
Baehner, F. L.
Soussan-Gutman, L.
Klang, S.
Yoshizawa, C.
Shak, S.
Siegelmann-Danieli, N.
机构：
[1] Clalit Hlth Serv, Tel Aviv, Israel
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Teva Pharmaceut Ind, Netanya, Israel
[4] Genom Hlth, Redwood City, CA USA
[5] Maccabi Hlth Org, Tel Aviv, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.632
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
632
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20
    Tang, Gong
    Shak, Steven
    Paik, Soonmyung
    Anderson, Stewart J.
    Costantino, Joseph P.
    Geyer, Charles E., Jr.
    Mamounas, Eleftherios P.
    Wickerham, D. Lawrence
    Wolmark, Norman
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (01) : 133 - 142
  • [42] Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20
    Gong Tang
    Steven Shak
    Soonmyung Paik
    Stewart J. Anderson
    Joseph P. Costantino
    Charles E. Geyer
    Eleftherios P. Mamounas
    D. Lawrence Wickerham
    Norman Wolmark
    Breast Cancer Research and Treatment, 2011, 127 : 133 - 142
  • [43] Association between the 21-gene recurrence score assay (RS) and risk of locoregional failure in node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20.
    Mamounas, E
    Tang, G
    Bryant, J
    Paik, S
    Shak, S
    Costantino, J
    Watson, D
    Wickerham, DL
    Wolmark, N
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S16 - S16
  • [44] Impact of the 21-Gene Recurrence Score Assay Compared With Standard Clinicopathologic Guidelines in Adjuvant Therapy Selection for Node-Negative, Estrogen Receptor-Positive Breast Cancer
    Partin, Jessica F.
    Mamounas, Eleftherios P.
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (12) : 3399 - 3406
  • [45] Impact of the 21-Gene Recurrence Score Assay Compared With Standard Clinicopathologic Guidelines in Adjuvant Therapy Selection for Node-Negative, Estrogen Receptor-Positive Breast Cancer
    Jessica F. Partin
    Eleftherios P. Mamounas
    Annals of Surgical Oncology, 2011, 18 : 3399 - 3406
  • [46] Impact of the Oncotype DX® Recurrence Score® Assay on therapy recommendations for ER-positive (ER+), node negative (N0) and node positive (N+) early breast cancer - Results of an interim analysis of the German decision impact study
    Blohmer, J. -U.
    Rezai, M.
    Kuemmel, S.
    Kuehn, T.
    Warm, M.
    Friedrichs, K.
    Schneeweiss, A.
    Markmann, S.
    Eggemann, H.
    Hilfrich, J.
    Jackisch, C.
    Witzel, I
    Eidtmann, H.
    Kaufmann, M.
    Eiermann, W.
    ONKOLOGIE, 2011, 34 : 119 - 120
  • [47] A novel 95-gene signature (Curebest 95GC Breast) that predicts recurrence-risk in patients with ER-positive, HER2-negative, node-negative, early-stage primary invasive breast cancer with an intermediate Oncotype DX Recurrence Score.
    Fujii, Takeo
    Masuda, Hiroko
    Cheng, Yee Chung
    Yang, Fei
    Sahin, Aysegul A.
    Naoi, Yasuto
    Matsunaga, Yuki
    Raghavendra, Akshara Singareeka
    Sinha, Arup Kumar
    Fernandez, Jose R. Espinosa
    James, Anjali
    Yamagishi, Keisuke
    Matsushima, Tomoko
    Tripathy, Debu
    Tada, Sachiyo
    Jackson, Rubie S.
    Noguchi, Shinzaburo
    Nakamura, Seigo
    Acoba, Jared David
    Ueno, Naoto T.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] Peer review report 1 on "Predictive factors for the occurrence of four or more axillary lymph node metastases in ER-positive and HER2-negative breast cancer patients with positive sentinel node: A retrospective cohort study"
    Leinster, Sam
    INTERNATIONAL JOURNAL OF SURGERY, 2016, 25 : 51 - 51
  • [49] Peer review report 2 on "Predictive factors for the occurrence of four or more axillary lymph node metastases in ER-positive and HER2-negative breast cancer patients with positive sentinel node: A retrospective cohort study"
    Nunez De Pierro, Anibal Roberto
    INTERNATIONAL JOURNAL OF SURGERY, 2016, 25 : 41 - 42
  • [50] Estrogen Receptor-Positive/HER2-Negative and Lymph Node-Negative Breast Cancers Have Similar Oncotype DX Recurrence Score Distribution and Prognosis in African American and Caucasian Patients
    Logan, Suzanna J.
    Zhang, Chao
    Liu, Yuan
    Siddiqui, Momin T.
    Cohen, Cynthia
    Li, Xiaoxian
    LABORATORY INVESTIGATION, 2017, 97 : 56A - 57A
12345